China-Universal-Asset-Management-Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-30
Total Holdings
486
Total Value
1074810188
Accession Number
0001906594-25-000002
Form Type
13F-HR
Manager Name
China-Universal-Asset-Management-Co
Data Enrichment
96% identified
465 identified21 unidentified

Holdings

486 positions
Manager:
Search and click to pin securities to the top
Page 16 of 25
Pacira BioSciences, Inc.
Shares:9.3K
Value:$230.7K
NIKE, Inc.
Shares:3.6K
Value:$229.0K
Innoviva, Inc.
Shares:12.6K
Value:$227.9K
Aurinia Pharmaceuticals Inc.
Shares:27.5K
Value:$221.5K
Astera Labs, Inc.
Shares:3.7K
Value:$220.8K
Adaptive Biotechnologies Corp
Shares:29.6K
Value:$219.9K
IOVANCE BIOTHERAPEUTICS, INC.
Shares:65.8K
Value:$219.0K
PULSE BIOSCIENCES, INC.
Shares:13.6K
Value:$218.0K
89bio, Inc.
Shares:29.3K
Value:$212.9K
Syndax Pharmaceuticals Inc
Shares:17.1K
Value:$210.3K
Structure Therapeutics Inc.
Shares:12.0K
Value:$206.9K
NOVAVAX INC
Shares:32.3K
Value:$206.8K
GERON CORP
Shares:127.8K
Value:$203.1K
Spyre Therapeutics, Inc.
Shares:12.1K
Value:$195.0K
Enliven Therapeutics, Inc.
Shares:9.8K
Value:$192.9K
HARROW, INC.
Shares:7.1K
Value:$190.0K
10x Genomics, Inc.
Shares:21.7K
Value:$189.5K
COLLEGIUM PHARMACEUTICAL, INC
Shares:6.3K
Value:$188.5K
Kiniksa Pharmaceuticals International, plc
Shares:8.4K
Value:$187.1K
Nurix Therapeutics, Inc.
Shares:15.2K
Value:$180.8K